Neovasc achieves design freeze for Transfemoral Trans-septal Tiara mitral valve system
The TF/TS Tiara System allows for a controlled and predictable implantation procedure similar to Neovasc’s Tiara transapical device
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Feb 20
The TF/TS Tiara System allows for a controlled and predictable implantation procedure similar to Neovasc’s Tiara transapical device
11 Feb 20
RIST Neurovascular, Inc is focused on creating a portfolio of access products designed to allow neuroendovascular procedures to…
07 Feb 20
BioVentrix is a privately held medical device company aimed at improving the treatments available for congestive heart failure…
06 Feb 20
JenaValve develops and manufactures Pericardial Transcatheter Aortic Valve Replacement (TAVR) System for the treatment of aortic valve disease
05 Feb 20
The HeartLight X3 System is a third generation AFib ablation technology designed based on the advanced features of…
04 Feb 20
Abbott secured CE mark approval for the Amplatzer Amulet device in 2013
31 Jan 20
Tendyne TMVI system is indicated for treating mitral regurgitation (MR) in patients, who need heart valve replacement and…
31 Jan 20
The new implantable heart devices are compatible with the TriageHF technology
30 Jan 20
CytoSorb has been approved with expanded label indication for the removal of the anti-platelet agent ticagrelor, during cardiopulmonary…
30 Jan 20
VADovations is developing ultra-miniaturized blood pumps designed for minimally invasive and percutaneous, endovascular deployment while addressing the total…